Characterization of myelodysplastic syndromes (MDS) with T-cell large granular lymphocyte proliferations (LGL)
Leukemia
.
2020 Nov;34(11):3097-3099.
doi: 10.1038/s41375-020-0928-4.
Epub 2020 Jun 21.
Authors
Rami S Komrokji
1
,
Najla Al Ali
2
,
David Sallman
2
,
Eric Padron
2
,
Jeffrey Lancet
2
,
Lubomir Sokol
2
,
Christa Varnadoe
3
,
P K Burnette
4
,
Alan List
5
Affiliations
1
Department of Malignant Hematology, H. Lee Moffitt Cancer center, Tampa, FL, USA. Rami.komrokji@moffitt.org.
2
Department of Malignant Hematology, H. Lee Moffitt Cancer center, Tampa, FL, USA.
3
Yale School of Nursing, New Haven, CT, USA.
4
James A Haley Veterans Hospital, Tampa, FL, USA.
5
Formerly Department of Malignant Hematology, H. Lee Moffitt Cancer center, Tampa, FL, USA.
PMID:
32565544
DOI:
10.1038/s41375-020-0928-4
No abstract available
Publication types
Letter
Comment
MeSH terms
Cell Proliferation
Humans
Killer Cells, Natural
Leukemia, Large Granular Lymphocytic* / diagnosis
Myelodysplastic Syndromes* / diagnosis
T-Lymphocytes